CoChat

Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats

Open access
Pan, Qing, Xu, Qingguo, Boylan, Nicholas J., Lamb, Nicholas W., G. Emmert, David, Yang, Jeh-Chang, Tang, Li, Heflin, Tom, Alwadani, Saeed, Eberhart, Charles G., Stark, Walter J., Hanes, Justin · 2015 · Journal of Controlled Release
Cited by 94

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Immunologic graft rejection is one of the main causes of short and long-term graft failure in corneal transplantation. Steroids are the most commonly used immunosuppressive agents for postoperative management and prevention of corneal graft rejection. However, steroids delivered in eye drops are rapidly cleared from the surface of the eye, so the required frequency of dosing for corneal graft rejection management can be as high as once every 2 h. Additionally, these eye drops are often prescribed for daily use for 1 year or longer, which can result in poor patient compliance and steroid-related side effects. Here, we report a biodegradable nanoparticle system composed of Generally Regarded as Safe (GRAS) materials that can provide sustained release of corticosteroids to prevent corneal graft rejection following subconjunctival injection provided initially during transplant surgery. Poly(lactic-co-glycolic acid) (PLGA) nanoparticles containing dexamethasone sodium phosphate (DSP) exhibited a size of 200 nm, 8 wt.% drug loading, and sustained drug release over 15 days in vitro under sink conditions. DSP-loaded nanoparticles provided sustained ocular drug levels for at least 7 days after subconjunctival administration in rats, and prevented corneal allograft rejection over the entire 9-week study when administered weekly. In contrast, control treatment groups that received weekly injections of either placebo nanoparticles, saline, or DSP in solution demonstrated corneal graft rejection accompanied by severe corneal edema, neovascularization and opacity that occurred in ≤ 4 weeks. Local controlled release of corticosteroids may reduce the rate of corneal graft rejection, perhaps especially in the days immediately following surgery when risk of rejection is highest and when typical steroid eye drop administration requirements are particularly onerous.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2015.01.009

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 94

Metadata

Authors
Pan, Q., Xu, Q., Boylan, N. J., Lamb, N. W., G. Emmert, D., Yang, J.-C., Tang, L., Heflin, T., Alwadani, S., Eberhart, C. G., Stark, W. J., & Hanes, J.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2015-03
Volume
201
Pages
32-40
ISSN
0168-3659 (ISSN-L)
OpenAlex
W2063707766
Cited by
94
References
4
FWCI
4.37
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats. https://app.cochat.ai/papers/10.1016/j.jconrel.2015.01.009
The paper
Pan, Q., Xu, Q., Boylan, N. J., Lamb, N. W., G. Emmert, D., Yang, J.-C., Tang, L., Heflin, T., Alwadani, S., Eberhart, C. G., Stark, W. J., & Hanes, J. (2015). Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2015.01.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.